Beam nasdaq
WebApr 6, 2024 · BEAM opened at $29.32 on Thursday. Beam Therapeutics Inc. has a 12 month low of $27.77 and a 12 month high of $73.27. The stock has a market capitalization of $2.12 billion, a price-to-earnings ratio of -7.10 and a beta of 1.64. The business has a fifty day moving average price of $38.08 and a 200 day moving average price of $42.41. Web1 day ago · Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of …
Beam nasdaq
Did you know?
WebNov 14, 2024 · Beam Therapeutics Inc. is estimated to report earnings on 11/14/2024. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks ... Web2 days ago · Beam Therapeutics Inc. is a biotechnology company. The Company is focused on developing precision genetic medicines based on its base editing technology to provide life-long cures to patients suffering from diseases. Its base editing technology enables a new class of precision genetic medicines that targets a single base in the …
WebApr 10, 2024 · Beam Therapeutics Price Performance. NASDAQ:BEAM opened at $29.74 on Monday. The firm has a market capitalization of $2.15 billion, a P/E ratio of -7.20 and … WebApr 12, 2024 · According to analysts' consensus price target of $26.33, Beam Global has a forecasted upside of 113.9% from its current price of $12.31. Amount of Analyst Coverage Beam Global has only been the subject of 2 research reports in the past 90 days. See Top Rated MarketRank™ Stocks Here About Beam Global (NASDAQ:BEEM) Stock
WebSep 8, 2024 · Find the latest SEC Filings data for Beam Therapeutics Inc. Common Stock (BEAM) at Nasdaq.com. WebBeam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing...
WebFind real-time BEAM - Beam Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Beam Therapeutics Inc (NASDAQ:BEAM) 29.76. Delayed Data. As of Apr 12 -0.33 ...
WebApr 14, 2024 · The current stock price for Beam Therapeutics Inc. (BEAM) is $32.24. The stock experienced a significant increase during the last trading session, reaching $32.82 after opening at $30.00. It dipped to a low of $29.90 before ultimately closing at $29.75. Top 5 EV Tech Stocks to Buy for 2024 latest phone in pakistanlatest russian military losses ukraineWebBEAM Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 266 Institutional Holders 54,243,673 Total Shares Held Back to BEAM Overview Institutional Holdings... latest punjabi style kurta pajamaWebMay 10, 2024 · There are some variant perceptions on Beam Therapeutics, with the most bullish analyst valuing it at US$154 and the most bearish at US$62.00 per share. This is a fairly broad spread of estimates,... latest russian losses in ukraine todayWebView the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ. latest russian anti tank missilesWebBEAM THERAPEUTICS INC. 29.74. at close. +0.42 ( +1.43%) after hours • as of Apr 6, 07:51 PM EDT. 29.89. +0.15 ( +0.50%) 1D. 5D. latest russian losses in ukrainenowWebApr 13, 2024 · Beam Therapeutics (NASDAQ:BEAM) has a market capitalization of $2.15 billion and generates $60.92 million in revenue each year. The company earns $-289,090,000.00 in net income (profit) each … latest russian losses in ukraine